Indian Company Master Data Made Simple
Glenmark Pharmaceuticals Limited
Profile data last updated: 14/12/2024
Incorporated in 1977, Glenmark Pharmaceuticals Limited has a history spanning 4 decades. The company’s Corporate Identification Number is L24299MH1977PLC019982; registration no. 19982. Glenmark Pharmaceuticals Limited is registered as company limited by shares. Its authorized share capital is ₹277.00 crore. Glenmark Pharmaceuticals Limited’s paid-up capital stands at ₹28.22 crore.
Its primary business activity involves manufacture of other chemical products. Its registered office is located in Mumbai. Its registered address is B-2mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, India, 400026. Currently, the company’s operational status is active. Glenmark Pharmaceuticals Limited holds PAN AAACG2207L. The company has been issued the Legal Entity Identifier code 335800WKECZXIIT9GK20. For correspondence, the registered email address is [email protected]. The company’s top executive team comprises V S Mani (CFO).
Company Overview
- CIN
- Date of Incorporation
- 18/11/1977
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹2,77,00,00,000.00
- Paid up Capital
- ₹28,21,88,156.00
- Activity
- Manufacture of other chemical products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹1,23,346.00L | ₹69,249.00L | ₹4,42,736.10L | ₹2,95,573.70L | ₹0.00L |
| Accumulated Depreciation | -₹2,79,347.50L | -₹2,49,239.70L | -₹2,26,414.90L | -₹2,00,447.30L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹7,20,048.40L | ₹6,51,107.70L | ₹9,53,241.70L | ₹7,64,516.80L | ₹0.00L |
| Tangible Book Value | ₹7,38,914.20L | ₹6,51,336.20L | ₹7,05,762.20L | ₹6,80,124.90L | ₹0.00L |
| Long Term Debt | ₹51,270.00L | ₹0.00L | ₹3,85,213.80L | ₹2,57,174.40L | ₹0.00L |
| Goodwill | ₹7,026.60L | ₹6,735.90L | ₹7,361.90L | ₹6,001.90L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,77,375.70L | ₹1,07,923.90L | ₹57,862.10L | ₹1,19,028.30L | ₹0.00L |
| Machinery Furniture Equipment | ₹3,63,506.90L | ₹3,28,297.00L | ₹3,26,383.60L | ₹3,46,124.00L | ₹0.00L |
| Total Assets | ₹16,04,955.40L | ₹14,35,862.40L | ₹19,37,167.60L | ₹17,08,328.80L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹8,84,907.00L | ₹7,84,754.70L | ₹9,83,925.90L | ₹9,43,812.00L | ₹0.00L |
| Gross PPE | ₹6,68,132.70L | ₹6,06,021.90L | ₹6,48,562.30L | ₹6,65,802.30L | ₹0.00L |
| Common Stock | ₹2,821.90L | ₹2,821.90L | ₹2,821.70L | ₹2,821.70L | ₹0.00L |
| Total Capitalization | ₹9,36,214.10L | ₹7,84,792.70L | ₹13,32,606.10L | ₹11,65,839.10L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹1,46,029.90L | ₹1,33,456.50L | ₹2,41,630.10L | ₹2,28,539.80L | ₹0.00L |
| Total Debt | ₹2,47,266.70L | ₹1,23,093.00L | ₹4,60,788.10L | ₹3,96,202.10L | ₹0.00L |
| Other Equity Interest | ₹906.50L | ₹1,823.10L | ₹1,761.70L | ₹1,630.10L | ₹0.00L |
| Capital Stock | ₹2,821.90L | ₹2,821.90L | ₹2,821.70L | ₹2,821.70L | ₹0.00L |
| Additional Paid In Capital | ₹1,70,655.80L | ₹1,70,655.80L | ₹1,70,536.00L | ₹1,70,536.00L | ₹0.00L |
| Total Non Current Assets | ₹6,75,408.90L | ₹6,93,054.20L | ₹8,64,614.90L | ₹8,80,094.00L | ₹0.00L |
| Invested Capital | ₹11,04,363.60L | ₹8,83,852.30L | ₹13,82,164.30L | ₹12,75,699.60L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹1,69,146.60L | ₹1,67,040.10L | ₹1,17,328.90L | ₹1,44,340.10L | ₹0.00L |
| Net Tangible Assets | ₹7,38,914.20L | ₹6,51,336.20L | ₹7,05,762.20L | ₹6,80,124.90L | ₹0.00L |
| Cash And Cash Equivalents | ₹1,67,570.70L | ₹1,65,827.00L | ₹1,15,920.30L | ₹1,41,052.60L | ₹0.00L |
| Prepaid Assets | ₹64,238.10L | ₹56,888.10L | ₹64,122.80L | ₹70,651.30L | ₹0.00L |
| Stockholders Equity | ₹8,84,944.10L | ₹7,84,792.70L | ₹9,47,392.30L | ₹9,08,664.70L | ₹0.00L |
| Other Short Term Investments | ₹1,575.90L | ₹1,213.10L | ₹1,408.60L | ₹3,287.50L | ₹0.00L |
| Share Issued | ₹2,821.88L | ₹2,821.88L | ₹2,821.68L | ₹2,821.68L | ₹0.00L |
| Current Assets | ₹9,29,546.50L | ₹7,42,808.20L | ₹10,72,552.70L | ₹8,28,234.80L | ₹0.00L |
| Working Capital | ₹3,32,844.10L | ₹1,60,949.50L | ₹5,62,047.10L | ₹3,59,291.70L | ₹0.00L |
| Net Debt | ₹51,848.80L | ₹0.00L | ₹3,18,851.70L | ₹2,25,982.30L | ₹3,54,933.30L |
| Current Debt | ₹1,68,149.50L | ₹99,059.60L | ₹49,558.20L | ₹1,09,860.50L | ₹0.00L |
| Ordinary Shares Number | ₹2,821.88L | ₹2,821.88L | ₹2,821.68L | ₹2,821.68L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹69,891.00L | ₹15,169.10L | ₹4,02,926.00L | ₹2,77,173.80L | ₹0.00L |
| Current Liabilities | ₹5,96,702.40L | ₹5,81,858.70L | ₹5,10,505.60L | ₹4,68,943.10L | ₹0.00L |
| Net PPE | ₹3,88,785.20L | ₹3,56,782.20L | ₹4,22,147.40L | ₹4,65,355.00L | ₹0.00L |
| Retained Earnings | ₹8,79,853.90L | ₹7,87,044.90L | ₹9,45,703.90L | ₹9,21,090.70L | ₹0.00L |
| Construction In Progress | ₹56,848.60L | ₹44,966.90L | ₹1,09,220.10L | ₹96,292.20L | ₹0.00L |
| Other Non Current Assets | ₹17,903.10L | ₹14,923.10L | ₹15,385.70L | -₹1,59,533.60L | ₹0.00L |
| Common Stock Equity | ₹8,84,944.10L | ₹7,84,792.70L | ₹9,47,392.30L | ₹9,08,664.70L | ₹0.00L |
| Other Intangible Assets | ₹1,39,003.30L | ₹1,26,720.60L | ₹2,34,268.20L | ₹2,22,537.90L | ₹0.00L |
| Other Properties | ₹3,31,936.60L | ₹3,11,815.30L | ₹3,90,416.30L | ₹24,906.80L | ₹0.00L |
| Inventory | ₹3,02,853.00L | ₹2,51,305.10L | ₹2,37,362.00L | ₹2,49,983.30L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | -₹3,845.60L | ₹38,932.20L | ₹1,944.50L | ₹25,488.10L |
| Financing Cash Flow | ₹78,704.50L | -₹3,90,612.70L | -₹7,745.60L | -₹52,049.10L |
| Net Income | ₹1,04,709.70L | -₹1,50,166.80L | ₹29,724.50L | ₹99,360.00L |
| Investing Cash Flow | ₹209.40L | ₹4,56,089.30L | -₹52,849.10L | -₹33,328.00L |
| Free Cash Flow | -₹1,57,716.40L | -₹1,16,382.20L | ₹1,762.90L | ₹31,853.50L |
| End Cash Position | ₹1,67,570.70L | ₹1,65,827.00L | ₹1,44,302.60L | ₹1,41,052.60L |
| Capital Expenditure | -₹74,956.90L | -₹89,837.80L | -₹60,776.30L | -₹79,011.70L |
| Beginning Cash Position | ₹1,65,827.00L | ₹1,44,302.60L | ₹1,41,052.60L | ₹1,13,809.50L |
| Issuance Of Capital Stock | ₹0.00L | ₹120.00L | ₹0.00L | ₹1,01,185.40L |
| Operating Cash Flow | -₹82,759.50L | -₹26,544.40L | ₹62,539.20L | ₹1,10,865.20L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹5,150.80L | ₹6,261.20L | ₹5,559.90L | ₹3,535.40L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹1,04,709.70L | -₹1,89,899.60L | -₹16,971.60L | ₹94,171.10L |
| Net Income Discontinuous Operations | ₹0.00L | ₹39,732.80L | ₹46,696.10L | ₹0.00L |
| Basic EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹2,09,228.40L | ₹1,18,327.40L | ₹1,20,014.60L | ₹2,22,606.00L |
| Operating Revenue | ₹13,14,583.60L | ₹11,63,545.60L | ₹11,43,193.80L | ₹12,17,419.80L |
| Total Expenses | ₹11,27,736.90L | ₹11,00,438.10L | ₹10,35,306.40L | ₹10,33,415.00L |
| Total Unusual Items | -₹37,591.50L | -₹91,707.50L | -₹77,317.20L | -₹26,737.70L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹9,458.72L | -₹27,512.25L | -₹23,195.16L | -₹8,303.73L |
| Total Unusual Items Excluding Goodwill | -₹37,591.50L | -₹91,707.50L | -₹77,317.20L | -₹26,737.70L |
| Interest Income Non Operating | ₹4,393.50L | ₹617.60L | ₹700.00L | ₹943.50L |
| Interest Expense Non Operating | ₹20,706.50L | ₹51,596.90L | ₹34,903.60L | ₹29,809.90L |
| Interest Income | ₹4,393.50L | ₹617.60L | ₹700.00L | ₹943.50L |
| Net Income From Continuing And Discontinued Operation | ₹1,04,709.70L | -₹1,50,166.80L | ₹29,724.50L | ₹94,171.10L |
| General And Administrative Expense | ₹33,277.30L | ₹25,698.00L | ₹29,484.80L | ₹40,069.60L |
| Reconciled Depreciation | ₹48,601.00L | ₹63,081.00L | ₹61,126.80L | ₹48,671.50L |
| Net Income Continuous Operations | ₹1,04,714.20L | -₹1,83,085.00L | -₹8,956.10L | ₹99,364.90L |
| Reconciled Cost Of Revenue | ₹4,75,734.20L | ₹4,87,904.00L | ₹4,58,660.50L | ₹4,77,817.10L |
| Operating Income | ₹1,86,846.70L | ₹63,107.50L | ₹1,07,887.40L | ₹1,84,004.80L |
| Net Income | ₹1,04,709.70L | -₹1,50,166.80L | ₹29,724.50L | ₹94,171.10L |
| Diluted Average Shares | ₹2,822.10L | ₹2,821.79L | ₹2,821.68L | ₹2,821.68L |
| Selling And Marketing Expense | ₹1,27,051.50L | ₹1,09,227.30L | ₹1,13,719.60L | ₹89,630.70L |
| Normalized Income | ₹1,32,842.48L | -₹1,25,704.35L | ₹37,150.44L | ₹1,12,605.07L |
| Net Non Operating Interest Income Expense | -₹16,313.00L | -₹50,979.30L | -₹34,203.60L | -₹28,866.40L |
| EBIT | ₹1,60,627.40L | ₹55,246.40L | ₹58,887.80L | ₹1,73,934.50L |
| Gross Profit | ₹8,38,849.40L | ₹6,75,641.60L | ₹6,84,533.30L | ₹7,39,602.70L |
| Cost Of Revenue | ₹4,75,734.20L | ₹4,87,904.00L | ₹4,58,660.50L | ₹4,77,817.10L |
| Diluted NIAvailto Com Stockholders | ₹1,04,709.70L | -₹1,50,166.80L | ₹29,724.50L | ₹94,171.10L |
| Net Interest Income | -₹16,313.00L | -₹50,979.30L | -₹34,203.60L | -₹28,866.40L |
| Operating Expense | ₹6,52,002.70L | ₹6,12,534.10L | ₹5,76,645.90L | ₹5,55,597.90L |
| Normalized EBITDA | ₹2,46,819.90L | ₹2,10,034.90L | ₹1,97,331.80L | ₹2,49,343.70L |
| Net Income Common Stockholders | ₹1,04,709.70L | -₹1,50,166.80L | ₹29,724.50L | ₹94,171.10L |
| Pretax Income | ₹1,39,920.90L | ₹3,649.50L | ₹23,984.20L | ₹1,44,124.60L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹1,60,328.80L | ₹1,34,925.30L | ₹1,43,204.40L | ₹1,29,700.30L |
| Total Revenue | ₹13,14,583.60L | ₹11,63,545.60L | ₹11,43,193.80L | ₹12,17,419.80L |
| Other Operating Expenses | ₹1,40,549.60L | ₹1,31,907.90L | ₹1,16,117.70L | ₹1,26,320.20L |
| Diluted EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹20,706.50L | ₹51,596.90L | ₹34,903.60L | ₹29,809.90L |
| Basic Average Shares | ₹2,821.60L | ₹2,821.62L | ₹2,821.68L | ₹2,821.68L |
| Net Income Including Noncontrolling Interests | ₹1,04,714.20L | -₹1,43,352.20L | ₹37,740.00L | ₹99,364.90L |
| Tax Provision | ₹35,206.70L | ₹1,86,734.50L | ₹32,940.30L | ₹44,759.70L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 12/10/1998 | Glenn Mario Saldanha | 00050607 | Managing Director | View other directorships |
| 16/05/2007 | Cherylann Maria Pinto | 00111844 | Whole-time director | View other directorships |
| 14/08/2009 | Blanche Saldanha Elizabeth | 00007671 | Director | View other directorships |
| 02/02/2017 | Harish Vinayak Kuber | *****8790R | Company Secretary | |
| 31/03/2017 | Rajesh Vasudeo Desai | 00007960 | Director | View other directorships |
| 16/11/2017 | V S Mani | *****5727N | CFO | |
| 29/05/2018 | V S Mani | 01082878 | Whole-time director | View other directorships |
| 01/04/2019 | Sona Saira Ramasastry | 08398547 | Director | View other directorships |
| 14/08/2020 | Dipankar Bhattacharjee | 08770548 | Director | View other directorships |
| 10/02/2023 | Vijayalakshmi Iyer | 05242960 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 19/11/2024 | Form MGT-7-19112024_signed | - |
| 25/10/2024 | Form AOC-4(XBRL)-25102024 | - |
| 26/03/2024 | Form Addendum to AOC-4 CSR-26032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Bhatia Colour Chem Limited | L24290GJ2021PLC127878 | Plot No. A/2/12, Road No. 1, Udhana Udyog Nagar Sangh Udhna, Surat, Surat, Gujarat, India, 394210 |
| Chemfab Alkalis Limited | L24290TN2009PLC071563 | Team House, Gst Salai Vandalur, Chennai, Tamil Nadu, India, 600048 |
| Eastern Explosives And Chemicals Ltd | L24290WB1981PLC033598 | Chinpai P O Chinpai Birbhum Wb 731102 In |
| Senores Pharmaceuticals Limited | L24290GJ2017PLC100263 | 1101 To 1103, 11th Floor, South Tower, One 42 Opp. Jayantilal Park, Ambali Bopal Road,,ahmedabad,ahmedabad,gujarat,380054-india |
| Sree Maruthi Marine Industries Limited | L24290TN1973PLC006441 | No. 1/220, Kamaraj Street Kelambakkam, Kancheepuram, Tamil Nadu, India, 603103 |
Address
B-2mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, India, 400026
Frequently Asked Questions
What is the incorporation date of Glenmark Pharmaceuticals Limited?
The incorporation date of Glenmark Pharmaceuticals Limited is 18/11/1977.
What is the authorized share capital and paid-up capital of Glenmark Pharmaceuticals Limited?
The authorized share capital of Glenmark Pharmaceuticals Limited is ₹2,77,00,00,000.00. The paid-up capital is ₹28,21,88,156.00.
Who are the current board members & directors of Glenmark Pharmaceuticals Limited?
The current board member of Glenmark Pharmaceuticals Limited are:
- Glenn Mario Saldanha
- V S Mani
- Sona Saira Ramasastry
- Rajesh Vasudeo Desai
- Blanche Saldanha Elizabeth
- Cherylann Maria Pinto
- Dipankar Bhattacharjee
- Vijayalakshmi Iyer
What is the registered address of Glenmark Pharmaceuticals Limited?
The registered address of Glenmark Pharmaceuticals Limited is B-2mahalaxmi Chambers22 Bhulabhai Desai Road Mahalaxmi, Mumbai, Maharashtra, India, 400026.
What is the Corporate Identification Number of Glenmark Pharmaceuticals Limited?
The Corporate Identification Number of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982.